In organic chemistry, carbon-carbon bonds can be created using the Aldol Reaction. The reaction combines two carbonyl compounds (the first studies employed aldehydes) to generate a new -hydroxy carbonyl compound, and it was independently discovered by the Russian scientist Alexander Borodin in 1869 and by the French chemist Charles-Adolphe Wurtz in 1872. These goods are referred to as "aldols" since many of the items have the structural theme of aldehyde + alcohol. Many significant chemicals, whether they are created artificially or naturally, include aldol structural units. For instance, the aldol reaction has been utilised in the mass manufacture of the commodity chemical pentaerythritol and the synthesis of the heart disease medication Lipitor (atorvastatin, calcium salt). A more complex molecule is created when two relatively simple compounds undergo the aldol process. The formation of up to two additional stereogenic centres (on the carbons of the aldol adduct denoted with asterisks in the scheme below) results in an increase in complexity. Aldol reactions may now be carried out in high yield while also being controlled in terms of the relative and absolute configuration of these stereocenters. Because stereoisomers can have unique chemical and biological characteristics, the capacity to synthesis a certain stereoisomer selectively is important.
Title : Techniques for carbon dioxide sequestration and the way forward
Collin G Joseph, University Malaysia Sabah, Malaysia
Title : Application of vanadium and tantalum single-site zeolite catalysts in heterogeneous catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Indicators for evaluating green management practice of enterprises
Dai Yeun Jeong, Asia Climate Change Education Center and Jeju National University, Korea, Republic of
Title : DOZN™3.0 - A quantitative green chemistry evaluator for a sustainable future
Samy Ponnusamy, MilliporeSigma, United States
Title : Towards integrated biodesign-inspired translational platforms to co-develop innovative biotechnologies, biomanufacturing and biomarket-ing to revolutionize the future of the personalized & precision healthcare and life science bioindustry
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation